Literature DB >> 30734240

Predictive Value of Procalcitonin in Acute Severe Ulcerative Colitis: Not Quite PerfeCT?

Deok Whan Kim1, Jeong Min An1, Seong Pyo Hong1, Ki Baik Hahm2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30734240     DOI： 10.1007/s10620-019-05481-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn's disease.

Authors:  A Oussalah; V Laurent; O Bruot; J-L Guéant; D Régent; M-A Bigard; L Peyrin-Biroulet
Journal:  Aliment Pharmacol Ther       Date:  2010-09-16       Impact factor: 8.171

Review 2.  Surgery in ulcerative colitis: When? How?

Authors:  Gaetano Gallo; Paulo Gustavo Kotze; Antonino Spinelli
Journal:  Best Pract Res Clin Gastroenterol       Date:  2018-06-14       Impact factor: 3.043

3.  Differentiating Clostridium difficile Colitis from Clostridium difficile Colonization in Ulcerative Colitis: A Role for Procalcitonin.

Authors:  Andrew R Reinink; Julajak Limsrivilai; Bethany A Reutemann; Tristan Feierabend; Emily Briggs; Krishna Rao; Peter D R Higgins
Journal:  Digestion       Date:  2017-10-14       Impact factor: 3.216

4.  Serum Procalcitonin as a Potential Early Predictor of Short-Term Outcomes in Acute Severe Ulcerative Colitis.

Authors:  Hui-Min Wu; Juan Wei; Jin Li; Kai Wang; Lei Ye; Ying Qi; Bo-Si Yuan; Yu-Lin Yang; Li Zhao; Zhao Yang; Miao-Fang Yang; Jian-Feng Gong; Fang-Yu Wang
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

5.  Clinical significance of serum procalcitonin in patients with ulcerative colitis.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Kazuki Takakura; Shunichi Odahara; Shintaro Tsukinaga; Toyokazu Yukawa; Jimi Mitobe; Mikio Kajihara; Kan Uchiyama; Hiroshi Arakawa; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

Review 6.  Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis.

Authors:  Christina Wacker; Anna Prkno; Frank M Brunkhorst; Peter Schlattmann
Journal:  Lancet Infect Dis       Date:  2013-02-01       Impact factor: 25.071

7.  Role of procalcitonin in infectious gastroenteritis and inflammatory bowel disease.

Authors:  Kelvin Teck-Joo Thia; Edwin Shih-Yen Chan; Khoon-Lin Ling; Wai-Yoong Ng; Edward Jacob; Choon-Jin Ooi
Journal:  Dig Dis Sci       Date:  2008-04-16       Impact factor: 3.199

8.  Procalcitonin as a predictive biomarker for total body irradiation-induced bacterial load and lethality in mice.

Authors:  Prabath G Biju; Sarita Garg; Wenze Wang; Mashkoor A Choudhry; Elizabeth J Kovacs; Louis M Fink; Martin Hauer-Jensen
Journal:  Shock       Date:  2012-08       Impact factor: 3.454

9.  Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.

Authors:  A Croft; A Walsh; J Doecke; R Cooley; M Howlett; G Radford-Smith
Journal:  Aliment Pharmacol Ther       Date:  2013-06-20       Impact factor: 8.171

Review 10.  Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities.

Authors:  Giuseppe Lippi; Fabian Sanchis-Gomar
Journal:  World J Gastroenterol       Date:  2017-12-21       Impact factor: 5.742
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.